MJ CLINE, DW GOLDE, RJ BILLING, JE … - Annals of Internal Medicine, 1979 - Am Coll Physicians A fundamental abnormality in acute myeloid leukemia is a block in cell
differentiation with resultant accumulation of immature leukocytes. This
abnormality can be studied in continuously growing leukemic cell lines that ... Cited by 22 - Related articles
WG Peters, R Willemze, LP Colly - Scandinavian Journal of Haematology, 1986 - interscience.wiley.com Fifty two patients (aged 15–57 years) with primarily failed and relapsed acute
myelogenous (AML) or lymphoblastic leukemia (ALL) and with high-grade
non-Hodgkin's lymphoma (NHL) have been treated with intermediate dose ... Cited by 8 - Related articles - All 2 versions
JD Hines, JJ Mazza, MM Oken, JM Bennett, DJ … - Seminars in oncology, 1985 - ncbi.nlm.nih.gov 1: Semin Oncol. 1985 Jun;12(2 Suppl 3):117-9. High-dose cytosine arabinoside
and mAMSA induction and consolidation in patients with ... Cited by 9 - Related articles
R Willemze, WE Fibbe, FE Zwaan - The Netherlands journal of medicine, 1983 - ncbi.nlm.nih.gov 1: Neth J Med. 1983;26(8):215-9. Experience with intermediate- and high-dose cytosine
arabinoside in relapsed and refractory acute leukaemia. ... Cited by 12 - Related articles
[CITATION] Indications for the administration of platelet transfusions during remission induction therapy …
A Rohatiner, ML Slevin, HS Dhaliwal, JS … - Cancer chemotherapy and pharmacology, 1984 - Springer Summary. Twenty-six patients with acute leukaemia and 14 with high-grade
lymphoma received cytosine arabinoside (ara-C) at a twice daily dose of 2 g/m 2
administered as a 3-h infusion. Thirty-four patients received 12 doses and ... Cited by 33 - Related articles - All 3 versions
J Bernard, M Boiron, A Manus, JP Levy, J … - National Cancer Institute monograph, 1964 - ncbi.nlm.nih.gov 1: Natl Cancer Inst Monogr. 1964 Oct;15:359-65. FACTORS INFLUENCING SURVIVAL
TIME IN PATIENTS WITH ACUTE LEUKEMIA. BERNARD J, BOIRON ... Cited by 9 - Related articles
F Takaku, A Urabe, H Mizoguchi, O Yamada, … - Seminars in oncology, 1985 - ncbi.nlm.nih.gov 1: Semin Oncol. 1985 Jun;12(2 Suppl 3):144-9. High-dose cytosine arabinoside
in the treatment of resistant acute leukemia. Takaku ... Cited by 10 - Related articles
- ►aacrjournals.org [PDF] CW Wan, TW Mak - Cancer Research, 1978 - AACR Previouswork has suggestedthat 1-fi-D-arabinofurano sylcytosine5'-triphosphateis
the active metaboliteof 1- @-o-arabinofuranosylcytosine. The amountof 1-/3-o-
arabi nofuranosylcytosine5'-trlphosphate formed in tissues hasbeen shownto ... Cited by 17 - Related articles - All 2 versions
